Statistics for Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor
Total visits
| views | |
|---|---|
| Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor | 248 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
Top country views
| views | |
|---|---|
| United States | 189 |
| Germany | 15 |
| Ukraine | 6 |
| United Kingdom | 5 |
| Sweden | 5 |
| Canada | 4 |
| Russia | 4 |
| China | 2 |
| Japan | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 54 |
| Fairfield | 30 |
| Ann Arbor | 24 |
| Kiez | 14 |
| Cambridge | 9 |
| Houston | 8 |
| Jacksonville | 7 |
| White Plains | 7 |
| Kiev | 6 |
| Indianapolis | 4 |
| Dearborn | 3 |
| Saint Petersburg | 3 |
| San Francisco | 3 |
| Stockholm | 3 |
| Toronto | 3 |
| Lake Mary | 2 |
| Mcallen | 2 |
| Washington | 2 |
| Abingdon | 1 |
| Baltimore | 1 |
| Beijing | 1 |
| Brooklyn | 1 |
| Guangzhou | 1 |
| Gunzenhausen | 1 |
| Kalmar | 1 |
| Lachine | 1 |
| London | 1 |
| Manchester | 1 |
| Marcus Hook | 1 |
| Moscow | 1 |
| New York | 1 |
| Norrtälje | 1 |
| Philadelphia | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Woburn | 1 |